Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 20 | 2022 | 121 | 6.760 |
Why?
|
| Sexual Partners | 21 | 2021 | 314 | 3.900 |
Why?
|
| HIV Infections | 27 | 2024 | 2303 | 2.700 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 126 | 1.790 |
Why?
|
| Sexual Behavior | 14 | 2019 | 609 | 1.720 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2021 | 12 | 1.420 |
Why?
|
| Risk-Taking | 14 | 2021 | 451 | 1.340 |
Why?
|
| Mexico | 21 | 2018 | 240 | 1.270 |
Why?
|
| Violence | 4 | 2022 | 134 | 1.210 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 125 | 1.190 |
Why?
|
| Prenatal Care | 2 | 2018 | 73 | 1.170 |
Why?
|
| Substance-Related Disorders | 7 | 2021 | 730 | 1.140 |
Why?
|
| Kenya | 8 | 2022 | 50 | 1.140 |
Why?
|
| Qualitative Research | 13 | 2019 | 446 | 1.050 |
Why?
|
| Adult | 37 | 2021 | 11712 | 1.030 |
Why?
|
| Interpersonal Relations | 9 | 2018 | 205 | 0.950 |
Why?
|
| Syringes | 2 | 2021 | 6 | 0.910 |
Why?
|
| Needle-Exchange Programs | 2 | 2021 | 6 | 0.910 |
Why?
|
| Female | 40 | 2022 | 20969 | 0.900 |
Why?
|
| Heroin | 3 | 2018 | 13 | 0.890 |
Why?
|
| Unsafe Sex | 8 | 2018 | 161 | 0.880 |
Why?
|
| Health Personnel | 3 | 2021 | 228 | 0.830 |
Why?
|
| Heroin Dependence | 2 | 2018 | 23 | 0.790 |
Why?
|
| Humans | 50 | 2024 | 37093 | 0.780 |
Why?
|
| Buprenorphine | 1 | 2021 | 21 | 0.760 |
Why?
|
| Sexually Transmitted Diseases | 7 | 2018 | 164 | 0.730 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 864 | 0.730 |
Why?
|
| Drug Users | 4 | 2022 | 46 | 0.720 |
Why?
|
| Young Adult | 18 | 2019 | 4268 | 0.710 |
Why?
|
| California | 8 | 2021 | 476 | 0.690 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 560 | 0.670 |
Why?
|
| Commerce | 2 | 2019 | 87 | 0.670 |
Why?
|
| Perinatal Care | 1 | 2018 | 15 | 0.660 |
Why?
|
| Postnatal Care | 1 | 2018 | 13 | 0.660 |
Why?
|
| Interviews as Topic | 10 | 2019 | 381 | 0.630 |
Why?
|
| Male | 32 | 2020 | 20025 | 0.620 |
Why?
|
| Spouses | 1 | 2017 | 30 | 0.610 |
Why?
|
| Crime | 1 | 2017 | 26 | 0.590 |
Why?
|
| Methamphetamine | 5 | 2021 | 159 | 0.560 |
Why?
|
| Family Characteristics | 3 | 2017 | 108 | 0.560 |
Why?
|
| Love | 1 | 2015 | 6 | 0.520 |
Why?
|
| Decision Making | 1 | 2017 | 203 | 0.520 |
Why?
|
| Social Sciences | 1 | 2014 | 4 | 0.500 |
Why?
|
| Trust | 2 | 2017 | 133 | 0.500 |
Why?
|
| United States | 11 | 2021 | 4223 | 0.490 |
Why?
|
| Needle Sharing | 3 | 2021 | 8 | 0.450 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 420 | 0.440 |
Why?
|
| Research | 1 | 2014 | 163 | 0.440 |
Why?
|
| Harm Reduction | 2 | 2024 | 21 | 0.410 |
Why?
|
| Condoms | 6 | 2014 | 135 | 0.400 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 385 | 0.390 |
Why?
|
| Drug and Narcotic Control | 1 | 2010 | 10 | 0.380 |
Why?
|
| Anti-Infective Agents | 3 | 2018 | 64 | 0.370 |
Why?
|
| Population Surveillance | 1 | 2012 | 238 | 0.370 |
Why?
|
| Ohio | 2 | 2021 | 14 | 0.360 |
Why?
|
| Data Collection | 4 | 2016 | 194 | 0.350 |
Why?
|
| Pregnancy | 3 | 2021 | 1549 | 0.340 |
Why?
|
| Adolescent | 9 | 2021 | 5363 | 0.330 |
Why?
|
| Bariatric Surgery | 2 | 2018 | 17 | 0.320 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 23 | 0.320 |
Why?
|
| Prevalence | 9 | 2022 | 1455 | 0.310 |
Why?
|
| Mass Screening | 1 | 2012 | 462 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2018 | 404 | 0.290 |
Why?
|
| Homosexuality, Male | 3 | 2018 | 458 | 0.290 |
Why?
|
| Infant, Newborn | 2 | 2021 | 894 | 0.290 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 1067 | 0.280 |
Why?
|
| Alcoholism | 2 | 2018 | 240 | 0.260 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2015 | 65 | 0.240 |
Why?
|
| Risk Factors | 9 | 2021 | 3562 | 0.230 |
Why?
|
| Pharmaceutical Preparations | 2 | 2024 | 75 | 0.220 |
Why?
|
| Feminism | 1 | 2022 | 3 | 0.220 |
Why?
|
| Social Support | 3 | 2014 | 394 | 0.210 |
Why?
|
| Middle Aged | 11 | 2019 | 10129 | 0.210 |
Why?
|
| Soft Tissue Infections | 1 | 2021 | 6 | 0.200 |
Why?
|
| Aggression | 1 | 2022 | 89 | 0.200 |
Why?
|
| Africa South of the Sahara | 3 | 2019 | 46 | 0.200 |
Why?
|
| Methadone | 1 | 2021 | 19 | 0.190 |
Why?
|
| Sex Factors | 2 | 2015 | 898 | 0.190 |
Why?
|
| Hepatitis C | 1 | 2022 | 125 | 0.190 |
Why?
|
| Negotiating | 2 | 2017 | 25 | 0.180 |
Why?
|
| Pharmaceutical Services | 1 | 2019 | 21 | 0.170 |
Why?
|
| Rectum | 1 | 2018 | 22 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 2721 | 0.160 |
Why?
|
| Role | 1 | 2017 | 10 | 0.160 |
Why?
|
| Telemedicine | 1 | 2021 | 182 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2024 | 208 | 0.150 |
Why?
|
| Safe Sex | 1 | 2017 | 76 | 0.150 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 10 | 0.140 |
Why?
|
| Photography | 1 | 2017 | 46 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2018 | 210 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 32 | 0.140 |
Why?
|
| Gender Identity | 1 | 2017 | 103 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 519 | 0.140 |
Why?
|
| Income | 1 | 2017 | 140 | 0.140 |
Why?
|
| Anthropology, Cultural | 1 | 2016 | 10 | 0.140 |
Why?
|
| Drug Contamination | 1 | 2016 | 7 | 0.140 |
Why?
|
| Vulnerable Populations | 2 | 2014 | 140 | 0.130 |
Why?
|
| Public Health | 3 | 2020 | 372 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 162 | 0.130 |
Why?
|
| Medically Underserved Area | 1 | 2015 | 104 | 0.120 |
Why?
|
| Contact Tracing | 1 | 2014 | 19 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 198 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 494 | 0.120 |
Why?
|
| Condoms, Female | 1 | 2014 | 1 | 0.120 |
Why?
|
| Public Policy | 1 | 2014 | 32 | 0.120 |
Why?
|
| Research Subjects | 1 | 2014 | 32 | 0.120 |
Why?
|
| Prisoners | 1 | 2015 | 83 | 0.120 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 190 | 0.110 |
Why?
|
| Cocaine | 1 | 2016 | 232 | 0.110 |
Why?
|
| Truth Disclosure | 1 | 2013 | 26 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 127 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2014 | 212 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 2012 | 6 | 0.100 |
Why?
|
| Sample Size | 1 | 2012 | 25 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2012 | 36 | 0.100 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 30 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 47 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2014 | 1378 | 0.100 |
Why?
|
| Child | 2 | 2017 | 3131 | 0.100 |
Why?
|
| Communication | 1 | 2013 | 180 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2014 | 325 | 0.100 |
Why?
|
| Age Factors | 1 | 2014 | 1033 | 0.100 |
Why?
|
| Aged | 2 | 2019 | 6741 | 0.090 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 18 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 164 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2014 | 1492 | 0.090 |
Why?
|
| Program Development | 1 | 2010 | 233 | 0.080 |
Why?
|
| Crime Victims | 2 | 2018 | 77 | 0.070 |
Why?
|
| Family Relations | 2 | 2015 | 46 | 0.060 |
Why?
|
| Hepatitis C Antibodies | 1 | 2022 | 10 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 68 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2022 | 62 | 0.050 |
Why?
|
| Abscess | 1 | 2021 | 7 | 0.050 |
Why?
|
| Police | 1 | 2020 | 17 | 0.050 |
Why?
|
| Self Care | 1 | 2021 | 159 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 31 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 27 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 291 | 0.040 |
Why?
|
| Health Policy | 1 | 2019 | 165 | 0.040 |
Why?
|
| Jealousy | 1 | 2015 | 2 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 974 | 0.030 |
Why?
|
| Homicide | 1 | 2015 | 15 | 0.030 |
Why?
|
| Women | 1 | 2014 | 27 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 37 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 81 | 0.030 |
Why?
|
| Prejudice | 1 | 2014 | 110 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 145 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2013 | 8 | 0.030 |
Why?
|
| Counseling | 1 | 2014 | 116 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 45 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 534 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 339 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 922 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 885 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1418 | 0.020 |
Why?
|